To our knowledge, this study is the first to investigate the metabolic mechanisms underlying plasmablast migration toward CXCL12 in humans; therefore, our findings can form the basis for further studies on the metabolic control of humoral immunity and plasma cell-related diseases, such as myelomas and autoimmune diseases. Here, CXCL12 is linked to plasma cell myeloma.